Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Conventional Double Lumen Tube

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Conventional Double Lumen Tube1
  • Vivasight Double Lumen Tube1
  • Lung Isolation Device1

Active Sponsors

  • University of Texas Southwestern Medical Center1
  • Laval University1

Top Investigators

Related Conditions

  • Bronchial Blocker1
  • Lung Isolation Device1
  • Videoassisted Thoracoscopic Surgery1
  • Onelung Ventilation1
  • Single Lung Ventilation1

Activity Timeline